documents: FDA-2003-P-0346-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-P-0346-0002 | FDA | FDA-2003-P-0346 | Proposed Rule re Microbiology Devices; Reclassification of Hepatitis A Virus (HAV) Serological Assays (IgM Antibody, IgG Antibody and Total Antibodies [IgM and IgG]) | Proposed Rule | NPR-Notice of Proposed Rule-Making | 2004-09-30T04:00:00Z | 2004 | 9 | 2004-09-29T04:00:00Z | 2004-12-30T04:59:59Z | 2024-11-25T16:34:43Z | 69FR58371 | 0 | 0 | 0900006480496e02 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref